Merck & Co. Inc. (MRK): Price and Financial Metrics

MRK POWR Grades

• MRK scores best on the Quality dimension, with a Quality rank ahead of 90.26% of US stocks.
• MRK's strongest trending metric is Quality; it's been moving up over the last 179 days.
• MRK's current lowest rank is in the Momentum metric (where it is better than 17.51% of US stocks).

MRK Stock Summary

• MRK has a market capitalization of $218,926,044,205 -- more than approximately 99.4% of US stocks.
• MERCK & CO INC's stock had its IPO on January 1, 1986, making it an older stock than 93.28% of US equities in our set.
• In terms of twelve month growth in earnings before interest and taxes, MERCK & CO INC is reporting a growth rate of 166.21%; that's higher than 90.24% of US stocks.
• If you're looking for stocks that are quantitatively similar to MERCK & CO INC, a group of peers worth examining would be PFE, NVS, CSCO, AZN, and NVO.
• MRK's SEC filings can be seen here. And to visit MERCK & CO INC's official web site, go to www.merck.com.

MRK Valuation Summary

• MRK's EV/EBIT ratio is 13.2; this is 22.22% higher than that of the median Healthcare stock.
• Over the past 243 months, MRK's price/sales ratio has gone up 1.7.

Below are key valuation metrics over time for MRK.

MRK Growth Metrics

Its year over year price growth rate is now at 13.27%.
• Its 3 year net cashflow from operations growth rate is now at 53.82%.
• Its year over year cash and equivalents growth rate is now at 22.56%.

Over the past 70 months, MRK's revenue has gone up $17,262,000,000.

The table below shows MRK's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-06-30	57,169	18,891	16,579
2022-03-31	53,978	17,079	14,180
2021-12-31	48,704	14,109	13,049
2021-09-30	49,151	13,084	7,197
2021-06-30	48,548	10,460	5,571
2021-03-31	48,018	11,337	7,028

MRK's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• MRK has a Quality Grade of B, ranking ahead of 77.57% of graded US stocks.
• MRK's asset turnover comes in at 0.535 -- ranking 75th of 682 Pharmaceutical Products stocks.
• XTNT, ACOR, and BDSI are the stocks whose asset turnover ratios are most correlated with MRK.

The table below shows MRK's key quality metrics over time.